Skip to main content
Log in

Langzeitergebnisse der ABCSG-8A-Studie

Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) et al. Lancet. 2011;378(9804):1707-16

  2. Kunkler IH et al. Lancet Oncol. 2015;16(3):266-73

  3. Blamey RW et al. Eur J Cancer. 2013;49(10):2294-302

  4. Fyles AW et al. N Engl J Med. 2004;351(10):963-70

  5. Hughes KS et al. J Clin Oncol. 2013;31(19):2382-7

  6. Pötter R et al. Int J Radiat Oncol Biol Phys. 2007;68(2):334-40

  7. Tinterri C et al. Ann Surg Oncol. 2014;21(2):408-15

  8. Matuschek C et al. Radiat Oncol. 2017;12(1):60

  9. Bundesinstitut für Bevölkerungsforschung. 2020. https://www.bib.bund.de/Permalink.html?id=10262290 abgerufen am 4. November 2020

  10. Borm KJ et al. Radiother Oncol. 2020;142:195-201

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marciana Nona Duma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krug, D., Duma, M. Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom . InFo Hämatol Onkol 23, 38–39 (2020). https://doi.org/10.1007/s15004-020-8307-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-020-8307-x

Navigation